PTGS2 and PGE2 could promote cancer progression by affecting the differentiation and survival of tumor-associated immune cells, and shifting the tumor microenvironment into an immunosuppressive environment (Wang & Dubois, 2010). The gene discussed is PTGS2; the disease is cancer.